Monatin tabletop sweetener compositions and methods of making same

Details for Australian Patent Application No. 2004263855 (hide)

Owner Cargill, Inc.

Inventors Hicks, Paula M.

Agent Davies Collison Cave

Pub. Number AU-A-2004263855

PCT Pub. Number WO2005/014839

Priority 60/492,014 01.08.03 US

Filing date 2 August 2004

Wipo publication date 17 February 2005

International Classifications

A23L 1/236 (2006.01) Foods or foodstuffs - Artificial sweetening agents

A21D 13/08 (2006.01) Finished or partly finished bakery products

A23F 3/00 (2006.01) Tea

A23F 5/00 (2006.01) Coffee

A23G 1/00 (2006.01) Cocoa

A23G 3/00 (2006.01) Sweetmeats

A23L 1/187 (2006.01) Foods or foodstuffs - Puddings

A23L 2/02 (2006.01) Non-alcoholic beverages - containing fruit or vegetable juices

A23L 2/60 (2006.01) Non-alcoholic beverages

C12P 17/10 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - Nitrogen as only ring hetero atom

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014839 Priority application(s): WO2005/014839

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263865-Methods and compositions for targeted cleavage and recombination

2004263845-Improved electrophysiological assays using oocytes that express human ENaC and the use of phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes